Summary
- Current Price
- As of today, BCRX price is $9.21, down -0.97% on
- Current Price All-Time High
- BCRX price is currently -75.28% below its historical high of $37.25 set on
- Market Cap
- BCRX current market cap is $2B, up +41.25% over the past 365 days
- PE Ratio
- BCRX current PE ratio is 7.66
- Revenue
- BCRX current annual revenue is $874.84M, up +94.10% year-over-year
- Next Earnings
- The next earnings release for BCRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | BioCryst Pharmaceuticals, Inc. |
| Ticker | NASDAQ: BCRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | biocryst.com |
| Employees | 580 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $9.21 | |
| Price, 1D Change | -0.97% | |
| $2B | ||
| - | ||
| 7.66 | ||
| 0.76 | ||
| $875M | ||
| Revenue, 1Y Change | +94.10% | |
| $1.21 | ||
| EPS, 1Y Change | +380.74% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $1.21 | ||
| EPS Estimate | N/A | $0.48 |
| EPS Est. Change | N/A | -60.40% |
| $874.84M | ||
| Revenue Estimate | N/A | $650.76M |
| Revenue Est. Change | N/A | -25.61% |
| Current Price | $9.21 | |
| Price Target | - | $20.00 |
| Price Tgt. Change | - | +117.16% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.36 | -$0.43 | -20.58% | |
| $0.49 | $1.21 | +146.37% | |
| $0.48 | N/A | -60.40% | |
| $0.80 | N/A | -33.57% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $449.28M | $450.71M | +0.32% | |
| $620.20M | $874.84M | +41.06% | |
| $650.76M | N/A | -25.61% | |
| $732.41M | N/A | -16.28% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $9.21 | |
| $7.96 | ||
| SMA 200 vs Price | -13.62% | |
| $7.42 | ||
| SMA 50 vs Price | -19.47% | |
| 0.76 | ||
| $0.42 | ||
| 69.86 | ||
| 73.11% | ||
| 50.57% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $874.84M | ||
| $1.21 | ||
| $855.76M | ||
| 97.66% | ||
| $340.99M | ||
| 38.98% | ||
| $263.86M | ||
| 30.16% | ||
| $342.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -3.91 | ||
| 2.06 | ||
| 2.03 | ||
| - | ||
| 7 | ||
| 2.44 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 7.66 | ||
| 2.61 | ||
| -19.17 | ||
| 7.26 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$119.15M | ||
| $274.95M | ||
| $514.16M | ||
| $404.35M | ||
| $633.31M | ||
| $196.07M | ||
| $465.69M | ||
| $40.08M | ||
| $15.83M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $610.98M | ||
| $514.77M | ||
| $20.46M | ||
| $348.65M | ||
| $1.39M | ||
| $0.00 | ||
| $3.53M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $329.88M | ||
| -$13.69M | ||
| -$332.44M | ||
| $2.47M | ||
| $327.41M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| RBC Capital | → | |
| HC Wainwright & Co. | → | |
| Citizens | → | |
| Needham | → | |
| Barclays | → | |
| Needham | → | |
| JMP Securities | → | |
| Cantor Fitzgerald | → | |
| Needham | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with BCRX
FAQ
What is the ticker symbol for BioCryst Pharmaceuticals, Inc.?
The ticker symbol for BioCryst Pharmaceuticals, Inc. is NASDAQ:BCRX
Does BioCryst Pharmaceuticals, Inc. pay dividends?
No, BioCryst Pharmaceuticals, Inc. does not pay dividends
What sector is BioCryst Pharmaceuticals, Inc. in?
BioCryst Pharmaceuticals, Inc. is in the Healthcare sector
What industry is BioCryst Pharmaceuticals, Inc. in?
BioCryst Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is BioCryst Pharmaceuticals, Inc. based in?
BioCryst Pharmaceuticals, Inc. is headquartered in United States
When did BioCryst Pharmaceuticals, Inc. go public?
BioCryst Pharmaceuticals, Inc. initial public offering (IPO) was on March 4, 1994
Is BioCryst Pharmaceuticals, Inc. in the S&P 500?
No, BioCryst Pharmaceuticals, Inc. is not included in the S&P 500 index
Is BioCryst Pharmaceuticals, Inc. in the NASDAQ 100?
No, BioCryst Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is BioCryst Pharmaceuticals, Inc. in the Dow Jones?
No, BioCryst Pharmaceuticals, Inc. is not included in the Dow Jones index
When was BioCryst Pharmaceuticals, Inc. last earnings report?
BioCryst Pharmaceuticals, Inc.'s most recent earnings report was on February 26, 2026
When does BioCryst Pharmaceuticals, Inc. report earnings?
The next expected earnings date for BioCryst Pharmaceuticals, Inc. is May 4, 2026
Data Sources & References
- BCRX Official Website www.biocryst.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/882796/000162828026012240/0001628280-26-012240-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882796/000162828026012240/0001628280-26-012240-index.htm
- BCRX Profile on Yahoo Finance finance.yahoo.com/quote/BCRX
- BCRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bcrx